Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04655326 · ClinicalTrials.gov registry record · NA

Probiotic Therapy for Children and Adults With Autism Spectrum Disorder

A NA study, sponsored by Arizona State University.

Completed
Registry status
NA
Development phase
296
Enrollment target

NCT04655326 is a NA study that has completed, run by Arizona State University. The registered enrollment target is 296 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04655326, a NA study, has completed, sponsored by Arizona State University.

COMPLETED
Registry status
NA
Development phase
296 participants
Enrollment target

Study Summary

This is a study of the effect of a customized probiotic on children and adults with autism, including effects on autism symptoms and gastrointestinal symptoms.

Interventions

  • DIETARY_SUPPLEMENT Flore

Trial Details

FieldValue
Enrollment Target 296 participants
Start Date 2020-10-15
Est. Completion 2025-07-12
Phase NA

Sponsor

Arizona State University

187 total trials

What the Registry Record Tells You About NCT04655326

The ClinicalTrials.gov registry entry for NCT04655326 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 296 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arizona State University, which has 187 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Flore is the first listed.

NCT04655326 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04655326 about?

NCT04655326 is a clinical study titled "Probiotic Therapy for Children and Adults With Autism Spectrum Disorder". This is a study of the effect of a customized probiotic on children and adults with autism, including effects on autism symptoms and gastrointestinal symptoms.

What is the current status of trial NCT04655326?

This trial is currently completed. It is a NA study. The enrollment target is 296 participants. The study started on 2020-10-15. Estimated completion is 2025-07-12.

What interventions are being tested in trial NCT04655326?

The interventions under investigation include: Flore (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04655326?

This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.